HIGHLIGHTS
- who: CASE REPORT and colleagues from the Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China, Department of have published the Article: Intestinal Haemorrhage and Colitis Induced by Treatment With Osimertinib for Non-Small-Cell Lung Carcinoma: A Case Report, in the Journal: (JOURNAL)
- what: Severe colitis is a rare adverse event associated with osimertinib.
SUMMARY
(Yang et_al, 2017). For gastrointestinal adverse effects, diarrhoea (Yi et_al, 2019), nausea, and decreased appetite are the most common all-cause adverse events (Jänne et_al, 2015). Among the TKIs, osimertinib is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.